SCHEMBL7445905

SCHEMBL7445905

O=C(O)C(CC1CC=NO1)(c1ccccc1)N1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 8/20 0.35
CYP2B6 P20813 1/20 0.35
KMT2A Q03164 3/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
MEN1 O00255 2/20 0.32
PKM P14618 2/20 0.32
STAT1 P42224 1/20 0.32
CYP2D6 P10635 4/20 0.32
CHRM2 P08172 3/20 0.32
CHRM1 P11229 3/20 0.32
KCNH2 Q12809 3/20 0.32
HTR1A P08908 2/20 0.32
OPRM1 P35372 2/20 0.32
LMNA P02545 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LYPLA2 O95372 1/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7505447 0.88 CHRM2 (0.34) CHRM3KMT2AMEN1CYP2D6CHRM2
SCHEMBL7445903 0.76 CHRM3 (0.38) CHRM3CYP2B6CYP2D6CHRM2CHRM1
SCHEMBL2125965 0.72 CHRM3 (0.48) CHRM3CYP2D6CHRM2CHRM1KCNH2
SCHEMBL2125962 0.72 CHRM3 (0.48) CHRM3CYP2D6CHRM2CHRM1KCNH2
SCHEMBL2126331 0.72 CHRM3 (0.48) CHRM3CYP2D6CHRM2CHRM1KCNH2
SCHEMBL2126336 0.72 CHRM3 (0.48) CHRM3CYP2D6CHRM2CHRM1KCNH2
SCHEMBL2127685 0.72 CYP2B6 (0.50) CHRM3CYP2B6KMT2ACYP2D6CHRM2
SCHEMBL2128439 0.72 CYP2B6 (0.50) CHRM3CYP2B6KMT2ACYP2D6CHRM2
SCHEMBL327106 0.71 CYP2B6 (0.45) CHRM3CYP2B6KMT2ACYP2D6CHRM2
SCHEMBL703097 0.70 CYP2B6 (0.44) CHRM3CYP2B6KMT2ACYP2D6CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131306-A2 ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-09-12 EP disclosed
WO-2000029406-A2 NOVEL ISOXAZOLINE FIBRINOGEN RECEPTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-05-25 WO disclosed